next Section 1: Applying modelling techniques to analyse (seroprevalence) data page 1 of 78 OVERVIEW This session discusses how we can use data on the prevalence of previous…

Slide 1Infections in the Elderly Part 1 Karen Greenberg, DO Slide 2 Infections in the Elderly Part 1 This Care of the Aging Medical Patient in the Emergency Room (CAMP ER…

Infections in the Elderly Part 2 Karen Greenberg, DO Infections in the Elderly Part 2 This Care of the Aging Medical Patient in the Emergency Room (CAMPER) presentation is…

FUTURE of PHASE 1, 2, and 3 TRIALS Philip Colangelo, Pharm.D., Ph.D. Office of Clinical Pharmacology & Biopharmaceutics FDA / CDER FDA Review Division Organization Office…

FUTURE of PHASE 1, 2, and 3 TRIALS Philip Colangelo, Pharm.D., Ph.D. Office of Clinical Pharmacology & Biopharmaceutics FDA / CDER FDA Review Division Organization Office…

Infections in the Elderly Part 1 Karen Greenberg, DO Infections in the Elderly Part 1 This Care of the Aging Medical Patient in the Emergency Room (CAMPER) presentation is…